Stockscreener 앱 받기
6.3334
2.82%
0.1234
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
Vivo Opportunity group reports 5.0% stake in Achieve Life Sciences | ACHV SEC FilingForm SCHEDULE 13G - Stock Titan
Achieve Life Sciences Joins Russell 2000 Index - 富途牛牛
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha
Achieve Life Sciences, Inc. Amends Certificate of Incorporation – SEC 8-K Filing Details and Company Information - Minichart
[8-K] ACHIEVE LIFE SCIENCES, INC. Reports Material Event - Stock Titan
ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits
ACHVAchieve Life Sciences Inc Latest SEC Filings - Finviz
Achieve Life Sciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Index - marketscreener.com
Achieve Life Sciences added to Russell 2000 index By Investing.com - Investing.com Nigeria
Achieve Life Sciences (ACHV) Joins Russell 2000 Index - GuruFocus
Achieve Life Sciences added to Russell 2000 index - Investing.com
Achieve Life Sciences Joins Russell 2000® Index - The Manila Times
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Index - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBIT forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to earnings forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Index - marketscreener.com
Price to sales forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBITDA forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to book forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Completeness Index - marketscreener.com
Achieve Life Sciences (ACHV) Receives Strong Buy Rating with $20 Target - GuruFocus
Raymond James resumes Achieve Life Sciences stock coverage with Strong Buy - Investing.com Canada
Achieve Life Sciences, Inc. Actuals & Estimates (NASDAQ:ACHV) - TradingView
Achieve Life Sciences, Inc. Actuals & Estimates (MUN:SP4P) - TradingView
ACHV Forecast — Price Target — Prediction for 2027 - TradingView
Achieve Life Sciences Inc (ACHV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Achieve Life Sciences (ACHV) Receives a Buy from Canaccord Genuity - The Globe and Mail
Canaccord reiterates Achieve Life Sciences stock rating after CRL By Investing.com - Investing.com India
Canaccord reiterates Achieve Life Sciences stock rating after CRL - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter By Investing.com - Investing.com India
Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish - Seeking Alpha
Achieve Life Sciences jumps despite cytisinicline CRL - MSN
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned - Sahm
Achieve Life Sciences (ACHV) Receives FDA Complete Response Lett - GuruFocus
Achieve Life Sciences stock falls after FDA issues response letter - Investing.com
ACHV Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus
Achieve Life Sciences (ACHV) Sees 10% Rise Despite FDA Complete Response Letter - GuruFocus
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug - Reuters
Achieve Life Sciences Shares Rise After Complete Response Letter From FDA - marketscreener.com
Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline - marketscreener.com
Achieve Life Sciences receives FDA rejection on manufacturing issues By Investing.com - Investing.com Nigeria
Achieve Life Sciences receives FDA rejection on manufacturing issues - Investing.com
La FDA américaine refuse d'autoriser le médicament anti-tabagique d'Achieve Life Sciences - TradingView
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA - The Manila Times
Achieve Life Sciences stock falls after FDA issues response letter By Investing.com - Investing.com India
0.70%
1.89%
자본화:
|
볼륨(24시간):